Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.
Cancers (Basel). 2022 Jun 30;14(13):3226. doi: 10.3390/cancers14133226.
Cancers (Basel). 2022.
PMID: 35804997
Free PMC article.
Results of the Austrian National Lung Cancer Audit.
Burghuber OC, Kirchbacher K, Mohn-Staudner A, Hochmair M, Breyer MK, Studnicka M, Mueller MR, Feurstein P, Schrott A, Lamprecht B, Eckmayr J, Renner F, Bolitschek J, Pohl W, Schenk P, Errhalt P, Cerkl P, Baumgartner B, Kneussl M, Hartl S.
Burghuber OC, et al. Among authors: feurstein p.
Clin Med Insights Oncol. 2020 Sep 10;14:1179554920950548. doi: 10.1177/1179554920950548. eCollection 2020.
Clin Med Insights Oncol. 2020.
PMID: 32963472
Free PMC article.
Item in Clipboard
A case of tracheobronchial amyloidosis treated with endoscopic debulking and external beam radiation therapy.
Firlinger I, Setinek U, Koller H, Feurstein P, Prosch H, Burghuber OC, Valipour A.
Firlinger I, et al. Among authors: feurstein p.
Pneumologie. 2013 Jul;67(7):398-400. doi: 10.1055/s-0033-1344186. Epub 2013 Jul 4.
Pneumologie. 2013.
PMID: 23828166
Free article.
Item in Clipboard
Durvalumab impacts progression-free survival while high-dose radiation >66 Gy improves local control without excess toxicity in unresectable NSCLC stage III: Real-world data from the Austrian radio-oncological lung cancer study association registry (ALLSTAR).
Zehentmayr F, Feurstein P, Ruznic E, Langer B, Grambozov B, Klebermass M, Hüpfel H, Feichtinger J, Minasch D, Heilmann M, Breitfelder B, Steffal C, Gastinger-Grass G, Kirchhammer K, Kazil M, Stranzl H, Dieckmann K; ALLSTAR group.
Zehentmayr F, et al. Among authors: feurstein p.
Radiother Oncol. 2024 Apr 21;196:110294. doi: 10.1016/j.radonc.2024.110294. Online ahead of print.
Radiother Oncol. 2024.
PMID: 38653380
Free article.
Item in Clipboard
Cite
Cite